RXi Pharmaceuticals to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation, a majority-owned subsidiary of CytRx Corporation (NASDAQ: CYTR), today announced that the Company’s President and CEO Tod Woolf, Ph.D. will present a corporate overview at the BIO CEO & Investor Conference in New York City on Tuesday, February 12, 2008 at 4:15 PM EST.

MORE ON THIS TOPIC